Geospiza, the Seattle-based maker of software to help researchers analyze genomic data, said today it has been awarded a $110,000 Small Business Innovation Research Grant from the National Human Genome Research Institute to improve methods for spotting rare gene mutations that may determine how a cancer cell grows, and whether it will resist treatment.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
